Cargando…
Disease Mongering in Drug Promotion: Do Governments Have a Regulatory Role?
Most regulatory agencies, says Mintzes, fail to treat regulation of drug promotion as a public health concern. Unless this changes, she says, the public can expect more unfettered disease mongering.
Autor principal: | Mintzes, Barbara |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434509/ https://www.ncbi.nlm.nih.gov/pubmed/16597181 http://dx.doi.org/10.1371/journal.pmed.0030198 |
Ejemplares similares
-
Government Inaction on Ratings and Government Subsidies to the US Film Industry Help Promote Youth Smoking
por: Millett, Christopher, et al.
Publicado: (2011) -
Evolution of drug regulations and regulatory innovation for anticancer drugs in China
por: Liu, Yang, et al.
Publicado: (2022) -
The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers
por: Cockburn, Robert, et al.
Publicado: (2005) -
Recent Shifts in Global Governance: Implications for the Response to Non-communicable Diseases
por: Sridhar, Devi, et al.
Publicado: (2013) -
Responsible Governance for Mental Health Research in Low Resource Countries
por: Yasamy, M. Taghi, et al.
Publicado: (2011)